2008 May – 2010 Dec

Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye…

EDCTP-Clinical Research and Product Development Fellow: Dr Amadou Hamidou Togo, MD, PhD, Université des Sciences Techniques et Technologiques de Bamako(USTTB), Faculty of Pharmacy (FAPH), Malaria Research and Training Center (MRTC) Grant Agreement number: TMA2019IF-2867 Grant Title: TMA2019 IF [ TOGO] Call for proposals: TMA2019 IF [ TOGO] The purpose of this Call for Proposals is to support researchers and members…

Evaluation of Seasonal Malaria Chemoprevention (SMC) pilot in Kita District, Mali U.S. President’s Malaria Initiative (PMI), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Seydou Doumbia, Alassane Dicko | Mali

Increasing the uptake of IPTp-SP through Seasonal Malaria Chemoprevention channel delivery (INTEGRATION study) R-Evolution Worldwide, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali, Research Institute of Health Sciences (IRSS), Burkina Faso | Kassoum Kayentao | Burkina Faso, Mali

West Africa Malaria Initiative (WAMI) Spanish Agency for International Development Cooperation (AECID), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Ogobara Doumbo | Africa, Western

Malaria in pregnant is a public health problem in sub Saharan countries where 11 million pregnancies are exposed to malaria infection. Plasmodium falciparum in pregnant can cause adverse maternal health and poor birth outcomes. Artemisin-based Combination Therapy (ACT) used in treatment of uncomplicated Plasmodium falciparum malaria in pregnant women has the efficacy in Africa. The…